Starting Mounjaro? Learn the common side effects you may experience week by week, how long they last, practical tips to reduce nausea and digestive symptoms, and when to seek medical advice.

Retatrutide is an investigational triple receptor agonist that targets GLP-1, GIP, and glucagon receptors for weight management and metabolic health. Learn how it works, the latest research, and why it is not yet approved in Malaysia.

Discover how GLP-1 and GIP hormones are transforming medical weight management. Learn how treatments such as semaglutide and tirzepatide help regulate appetite, blood sugar, and metabolism to support healthier, sustainable weight loss under medical supervision.

Mounjaro (Tirzepatide GLP-1 Agonist) is the latest innovative dual-action injectable treatment primarily used for treating type 2 diabetes and has also shown strong secondary effectiveness in weight loss.